Paramita Therapeutics Inc.

San Diego, CA

UEI
MRDLCLW1SH57
CAGE
8Q1B1
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Minority Owned Business
  • Asian-Pacific American Owned
  • Self Certified Small Disadvantaged Business
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
3490 Atlas St, San Diego, CA 92111, USA
Website
paramitatherapeutics.com
Founded
2018
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Paramita Therapeutics Inc.'s 2 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Novel multivalent psma-targeted taxane-conjugates for bone metastases in prostate cancer - project title: "novel… Grant · R43CA306207 National Cancer Institute $353,009
Sbir phase i: novel covid-19 dual-function therapeutic/vaccine product Grant · 2112166 National Science Foundation $255,990

Quick answers

What is Paramita Therapeutics Inc.'s UEI?

Paramita Therapeutics Inc.'s Unique Entity ID (UEI) in SAM.gov is MRDLCLW1SH57.

What is Paramita Therapeutics Inc.'s CAGE code?

Paramita Therapeutics Inc.'s CAGE code is 8Q1B1.

What is Paramita Therapeutics Inc.'s primary NAICS code?

Paramita Therapeutics Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Paramita Therapeutics Inc. located?

Paramita Therapeutics Inc.'s physical address in SAM.gov is 3490 Atlas St, San Diego, CA 92111, USA.

Is Paramita Therapeutics Inc. registered in SAM.gov?

Yes. Paramita Therapeutics Inc.'s SAM.gov registration is active through August 20, 2027.

What is Paramita Therapeutics Inc.'s most recent federal award?

Paramita Therapeutics Inc.'s most recent federal grant award is Novel multivalent psma-targeted taxane-conjugates for bone metastases in prostate cancer - project title: "novel… (R43CA306207), from National Cancer Institute, on September 24, 2025.

On GovTribe

See Paramita Therapeutics Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login